Skip to main content
SpringerLink
Log in

Benigne Prostatahyperplasie und Urolithiasis

Benign prostatic hyperplasia and urolithiasis

  • Übersichten
  • Published:
Der Urologe Aims and scope Submit manuscript

Zusammenfassung

Die Akademie-Frühjahresforen im Rahmen des Südwestdeutschen Kongresses in Tübingen und des Nordrhein-Westfälischen Kongresses in Aachen ermöglichen niedergelassenen und klinisch tätigen Urologen gleichermaßen einen kompakten Überblick über neue Entwicklungen. Der nachfolgende Artikel fasst die neuen Arbeiten wie z. B. die interventionelle Therapie, Harnsteine und extrakorporale Stoßwellenlithotripsie zur benignen Prostatahyperplasie und Urolithiasis zusammen.

Abstract

The Academy Spring Forums held as part of the Southwest German Congress in Tübingen and the Congress of North Rhine-Westphalia in Aachen offer urologists in private practice and likewise hospital urologists a compact overview of new developments. This article summarizes the newest work on e.g. interventional therapy, uroliths, and extracorporeal shock wave lithotripsy for benign prostatic hyperplasia and urolithiasis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Morishima S, Suzuki F, Nishimune A et al (2010) Visualization and tissue distribution of alpha1 L-adrenoceptor in human prostate by the fluorescently labeled ligand Alexa-488-silodosin. J Urol 183:812

    Article  PubMed  CAS  Google Scholar 

  2. Kawabe K, Yoshida M, Homma Y (2006) Silodosin, a new alpha1 A-adrenoceptor-selective antagonist for treating benign prostatic hyperplasia: results of a phase III randomized, placebo-controlled, double-blind study in Japanese men. BJU Int 98:1019

    Article  PubMed  CAS  Google Scholar 

  3. Chapple CR, Montorsi F, Tammela TL et al (2011) Silodosin therapy for lower urinary tract symptoms in men with suspected benign prostatic hyperplasia: results of an international, randomized, double-blind, placebo- and active-controlled clinical trial performed in Europe. Eur Urol 59:342

    Article  PubMed  CAS  Google Scholar 

  4. Falahatkar S, Mokhtari G, Pourreza F et al (2008) Celecoxib for treatment of nocturia caused by benign prostatic hyperplasia: a prospective, randomized, double-blind, placebo-controlled study. Urology 72:813

    Article  PubMed  Google Scholar 

  5. St Sauver JL, Jacobson DJ, McGree ME et al (2011) Associations between longitudinal changes in serum estrogen, testosterone, and bioavailable testosterone and changes in benign urologic outcomes. Am J Epidemiol 173:787

    Article  Google Scholar 

  6. Roehrborn CG, Barkin J, Siami P et al (2011) Clinical outcomes after combined therapy with dutasteride plus tamsulosin or either monotherapy in men with benign prostatic hyperplasia (BPH) by baseline characteristics: 4-year results from the randomized, double-blind Combination of Avodart and Tamsulosin (CombAT) trial. BJU Int 107:946

    Article  PubMed  CAS  Google Scholar 

  7. Roehrborn CG, Andriole GL, Wilson TH et al (2011) Effect of dutasteride on prostate biopsy rates and the diagnosis of prostate cancer in men with lower urinary tract symptoms and enlarged prostates in the Combination of Avodart and Tamsulosin trial. Eur Urol 59:244

    Article  PubMed  CAS  Google Scholar 

  8. Höfner K, Burkart M, Jacob G et al (2010) Symptomatic and quality of life response to tolterodine in subgroups of men with overactive bladder symptoms and presumed non-obstructive benign prostatic hyperplasia. World J Urol 28:353

    Article  PubMed  Google Scholar 

  9. Kaplan SA, Roehrborn CG, Abrams P et al (2011) Antimuscarinics for treatment of storage lower urinary tract symptoms in men: a systematic review. Int J Clin Pract (Epub ahead of print)

  10. Laydner HK, Oliveira P, Oliveira CR et al (2011) Phosphodiesterase 5 inhibitors for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a systematic review. BJU Int (in press)

  11. Mishriki SF, Grimsley SJ, Lam T et al (2011) TURP and sex: patient and partner prospective 12 yrs follow-up study. BJU Int (Epub ahead of print)

  12. Autorino R, Damiano R, Di Lorenzo G et al (2009) Four-year outcome of a prospective randomised trial comparing bipolar plasmakinetic and monopolar transurethral resection of the prostate. Eur Urol 55:922

    Article  PubMed  Google Scholar 

  13. Burke N, Whelan JP, Goeree L et al (2010) Systematic review and meta-analysis of transurethral resection of the prostate versus minimally invasive procedures for the treatment of benign prostatic obstruction. Urology 75:1015

    Article  PubMed  Google Scholar 

  14. Chen Q, Zhang L, Fan QL et al (2010) Bipolar transurethral resection in saline vs traditional monopolar resection of the prostate: results of a randomized trial with a 2-year follow-up. BJU Int 106:1339

    Article  PubMed  Google Scholar 

  15. Wendt-Nordahl G, Cao Y, Hacker A et al (2009) Transurethral resection of the prostate: defending its leading position in the management of benign prostatic enlargement. Minerva Urol Nefrol 61:291

    PubMed  CAS  Google Scholar 

  16. Capitan C, Blazquez C, Martin MD et al (2011) GreenLight HPS 120-w laser vaporization versus transurethral resection of the prostate for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia: a randomized clinical trial with 2-year follow-up. Eur Urol (Epub ahead of print)

  17. Sohn JH, Choi YS, Kim SJ et al (2011) Effectiveness and safety of photoselective vaporization of the prostate with the 120 w hps greenlight laser in benign prostatic hyperplasia patients taking oral anticoagulants. Korean J Urol 52:178

    Article  PubMed  Google Scholar 

  18. Ku JH, Cho MC, Kim HS et al (2010) Treatment satisfaction after 1 year high-power potassium-titanyl-phosphate photoselective vaporization of the prostate. Asian J Androl 12:728

    Article  PubMed  CAS  Google Scholar 

  19. Al-Ansari A, Younes N, Sampige VP et al (2010) GreenLight HPS 120-W laser vaporization versus transurethral resection of the prostate for treatment of benign prostatic hyperplasia: a randomized clinical trial with midterm follow-up. Eur Urol 58:349

    Article  PubMed  Google Scholar 

  20. Geavlete B, Dragutescu M, Multescu R et al (2009) TURIS plasma vaporization – initial Romanian experience with a new technology. J Med Life 2:325

    PubMed  CAS  Google Scholar 

  21. Bach T, Netsch C, Haecker A et al (2010) Thulium:YAG laser enucleation (VapoEnucleation) of the prostate: safety and durability during intermediate-term follow-up. World J Urol 28:39

    Article  PubMed  Google Scholar 

  22. Xia SJ, Zhuo J, Sun XW et al (2008) Thulium laser versus standard transurethral resection of the prostate: a randomized prospective trial. Eur Urol 53:382

    Article  PubMed  Google Scholar 

  23. Fu WJ, Zhang X, Yang Y et al (2010) Comparison of 2-microm continuous wave laser vaporesection of the prostate and transurethral resection of the prostate: a prospective nonrandomized trial with 1-year follow-up. Urology 75:194

    Article  PubMed  Google Scholar 

  24. Oeconomou A, Madersbacher H (2010) Botulinum neurotoxin A for benign prostatic hyperplasia. Curr Opin Urol 20:28

    Article  PubMed  Google Scholar 

  25. Knoll T, Schubert AB, Leusmann DB et al (2011) Urolithiasis through the ages – data from more than 200,000 stone analyses. J Urol (in press)

  26. Hsu TC, Chen J, Huang HS et al (2002) Association of changes in the pattern of urinary calculi in Taiwanese with diet habit change between 1956 and 1999. J Formos Med Assoc 101:5

    PubMed  Google Scholar 

  27. Dasgupta R, Hegarty N, Thomas K (2009) Emergency shock wave lithotripsy for ureteric stones. Curr Opin Urol 19:196

    Article  PubMed  Google Scholar 

  28. Kurtz M, Eisner B (2010) Antibiotic use after routine ureteroscopic stonetreatment. J Urol 183(54):e558

    Article  Google Scholar 

  29. Geavlete P, Multescu R, Geavlete B (2011) Retrograde flexible ureteroscopy: reshaping the upper urinary tract endourology. Arch Esp Urol 64:3

    PubMed  CAS  Google Scholar 

  30. Binbay M, Yuruk E, Akman T et al (2010) Is there a difference in outcomes between digital and fiberoptic flexible ureterorenoscopy procedures? J Endourol 24:1929

    Article  PubMed  Google Scholar 

  31. Traxer O, Geavlete B, Medina SG de et al (2011) Narrow-band imaging digital flexible ureteroscopy in detection of upper urinary tract transitional-cell carcinoma: initial experience. J Endourol 25:19

    Article  PubMed  Google Scholar 

  32. Hussain M, Acher P, Penev B et al (2011) Redefining the limits of flexible ureterorenoscopy. J Endourol 25:45

    Article  PubMed  Google Scholar 

  33. Bader MJ, Gratzke C, Walther S et al (2010) Efficacy of retrograde ureteropyeloscopic holmium laser lithotripsy for intrarenal calculi > 2 cm. Urol Res 38:397

    Article  PubMed  CAS  Google Scholar 

  34. Adiyat KT, Meuleners R, Monga M (2009) Selective postoperative imaging after ureteroscopy. Urology 73:490

    Article  PubMed  Google Scholar 

  35. Rosette J de la, Assimos D, Desai M et al (2011) The Clinical Research Office of the Endourological Society Percutaneous Nephrolithotomy Global Study: indications, complications, and outcomes in 5803 patients. J Endourol 25:11

    Article  PubMed  Google Scholar 

  36. Knoll T, Wezel F, Michel MS et al (2010) Do patients benefit from miniaturized tubeless percutaneous nephrolithotomy? A comparative prospective study. J Endourol 24:1075

    Article  PubMed  Google Scholar 

  37. Li LY, Gao X, Yang, M et al (2010) Does a smaller tract in percutaneous nephrolithotomy contribute to less invasiveness? A prospective comparative study. Urology 75(1):56–61

    Article  PubMed  Google Scholar 

  38. Shah HN, Sodha HS, Khandkar AA et al (2008) A randomized trial evaluating type of nephrostomy drainage after percutaneous nephrolithotomy: small bore v tubeless. J Endourol 22:1433

    Article  PubMed  Google Scholar 

  39. Scoffone CM, Cracco CM, Poggio M et al (2010) Endoscopic combined intrarenal surgery for high burden renal stones. Arch Ital Urol Androl 82:41

    PubMed  Google Scholar 

  40. Cormio L, Annese P, Corvasce T et al (2007) Percutaneous nephrostomy in supine position. Urology 69:377

    Article  PubMed  Google Scholar 

  41. Wu P, Wang L, Wang K (2011) Supine versus prone position in percutaneous nephrolithotomy for kidney calculi: a meta-analysis. Int Urol Nephrol 43:67

    Article  PubMed  Google Scholar 

Download references

Interessenkonflikt

Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.

Author information

Authors and Affiliations

  1. Urologische Klinik Sindelfingen, Klinikum Sindelfingen-Böblingen, Arthur-Gruber-Straße 70, 71065, Sindelfingen, Deutschland

    T. Knoll

  2. Klinik für Urologie und Kinderurologie, Phillips-Universität Marburg, Marburg, Deutschland

    R. Hofmann

  3. Urologische Klinik, Evangelisches Krankenhaus Oberhausen, Oberhausen, Deutschland

    K. Höfner

Authors
  1. T. Knoll
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R. Hofmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. K. Höfner
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to T. Knoll.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Knoll, T., Hofmann, R. & Höfner, K. Benigne Prostatahyperplasie und Urolithiasis. Urologe 50 (Suppl 1), 197 (2011). https://doi.org/10.1007/s00120-011-2673-9

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s00120-011-2673-9

Schlüsselwörter

Keywords

Search

Navigation